THERAPEUTIC CLASS

Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis

---

Surgery for cT1-2, N0-1, M1 or cT3, N0, M1 disease is associated with a 5-year survival of 25% and
does not appear to compromise outcomes when compared to non-operative therapy, supporting guidelines that
recommend surgery for very select patients with stage IV disease. However, surgery provides less benefit and
should be considered much less often for stage IV patients with mediastinal nodal disease or more locally advanced
tumors.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Oncology
Fonkopac
Carboplatin
Epirubicin

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment